Biogen to purchase San Francisco startup creating a drug for kidney illness for $1.2B – The Enterprise Journals

Biogen to buy San Francisco startup developing a drug for kidney disease for $1.2B  The Business Journals

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button